Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Payables (2016 - 2025)

Healthy Extracts (HYEX) has 11 years of Payables data on record, last reported at $231963.0 in Q3 2025.

  • For Q3 2025, Payables rose 17.77% year-over-year to $231963.0; the TTM value through Sep 2025 reached $231963.0, up 17.77%, while the annual FY2024 figure was $54674.0, 88.56% down from the prior year.
  • Payables reached $231963.0 in Q3 2025 per HYEX's latest filing, down from $355561.0 in the prior quarter.
  • Across five years, Payables topped out at $887908.0 in Q3 2021 and bottomed at $54674.0 in Q4 2024.
  • Average Payables over 5 years is $434630.9, with a median of $408600.0 recorded in 2022.
  • Peak YoY movement for Payables: skyrocketed 1431.67% in 2021, then crashed 88.56% in 2024.
  • A 5-year view of Payables shows it stood at $209017.0 in 2021, then soared by 95.49% to $408600.0 in 2022, then increased by 16.97% to $477935.0 in 2023, then crashed by 88.56% to $54674.0 in 2024, then soared by 324.27% to $231963.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $231963.0 in Q3 2025, $355561.0 in Q2 2025, and $574567.0 in Q1 2025.